Influence of dietary blueberry and broccoli on cecal microbiota activity and colon morphology in mdr1a -/- mice, a model of inflammatory bowel diseases

Nutrition

Volumn 28, Issue 3, 2012, Pages 324-330

  Paturi, Gunaranjan ^a   Mandimika, Tafadzwa ^a   Butts, Christine A ^a   Zhu, Shuotun ^b   Roy, Nicole C ^c,d   McNabb, Warren C ^c,d   Ansell, Juliet ^a,d  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c AGRESEARCH GRASSLANDS   (New Zealand)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

Bacterial translocation; Colon inflammation; Functional foods; Gut health; Large intestine; Short chain fatty acids

Indexed keywords

BUTYRIC ACID; CARBOXYLIC ACID; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL TRANSLOCATION; BLUEBERRY; BROCCOLI; CECUM; COLITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTERITIS; FAECALIBACTERIUM PRAUSNITZII; GOBLET CELL; INTESTINE FLORA; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLUEBERRY PLANT; BRASSICA; CECUM; COLON; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; FRUIT; FUNCTIONAL FOOD; INFLAMMATORY BOWEL DISEASES; MALE; METAGENOME; MICE; MICE, KNOCKOUT; VEGETABLES;

BACTERIA (MICROORGANISMS); BRASSICA OLERACEA VAR. ITALICA; FAECALIBACTERIUM PRAUSNITZII; MUS; VACCINIUM;

EID: 84856497594     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.07.018     Document Type: Article

References (39)

1. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
2. Zoetendal E.G., Akkermans A.D., De Vos W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998, 64:3854-3859.
3. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007, 104:13780-13785.
4. Mylonaki M., Langmead L., Pantes A., Johnson F., Rampton D.S. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004, 16:775-778.
5. Swidsinski A., Loening-Baucke V., Vaneechoutte M., Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008, 14:147-161.
6. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
7. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008, 8:411-420.
8. Turner J.R. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 2006, 169:1901-1909.
9. Larrosa M., Luceri C., Vivoli E., Pagliuca C., Lodovici M., Moneti G., et al. Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. Mol Nutr Food Res 2009, 53:1044-1054.
10. Osman N., Adawi D., Ahrne S., Jeppsson B., Molin G. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig Dis Sci 2008, 53:2464-2473.
11. Peng L., Li Z.-R., Green R.S., Holzman I.R., Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009, 139:1619-1625.
12. Paturi G., Butts C., Monro J., Nones K., Martell S., Butler R., et al. Cecal and colonic responses in rats fed 5 or 30% corn oil diets containing either 7.5% broccoli dietary fiber or microcrystalline cellulose. J Agric Food Chem 2010, 58:6510-6515.
13. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998, 161:5733-5744.
14. Huffman L., Sivakumaran S., Sharp K. New Zealand FOODfiles 2010 Manual 2010, The New Zealand Institute for Plant and Food Research Limited, Palmerston North, New Zealand.
15. Richardson A.J., Calder A.G., Stewart C.S., Smith A. Simultaneous determination of volatile and non-volatile acidic fermentation products of anaerobes by capillary gas chromatography. Lett Appl Microbiol 1989, 9:5-8.
16. Nones K., Dommels Y.E.M., Martell S., Butts C., McNabb W.C., Park Z.A., et al. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a(-/-)) mice, a model of inflammatory bowel diseases. Br J Nutr 2009, 101:169-181.
17. Falk A., Olsson C., Ahrne S., Molin G., Adawi D., Jeppsson B. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol 2007, 42:973-985.
18. Balish E., Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 2002, 160:2253-2257.
19. Kotlowski R., Bernstein C.N., Sepehri S., Krause D.O. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669-675.
20. Nones K., Knoch B., Dommels Y.E.M., Paturi G., Butts C., McNabb W.C., et al. Multidrug resistance gene deficient (mdr1a-/-) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. J Appl Microbiol 2009, 107:557-566.
21. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004, 70:5810-5817.
22. Vernia P., Caprilli R., Latella G., Barbetti F., Magliocca F.M., Cittadini M. Fecal lactate and ulcerative colitis. Gastroenterology 1988, 95:1564-1568.
23. Marquet P., Duncan S.H., Chassard C., Bernalier-Donadille A., Flint H.J. Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett 2009, 299:128-134.
24. Rowan F.E., Docherty N.G., Coffey J.C., O'Connell P.R. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 2009, 96:151-158.
25. Tedelind S., Westberg F., Kjerrulf M., Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: A study with relevance to inflammatory bowel disease. World J Gastroenterol 2007, 13:2826-2832.
26. Inagaki A., Ichikawa H., Sakata T. Inhibitory effect of succinic acid on epithelial cell proliferation of colonic mucosa in rats. J Nutr Sci Vitaminol 2007, 53:377-379.
27. Yasui Y., Hosokawa M., Mikami N., Miyashita K., Tanaka T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem Biol Interact 2011, 193:79-87.
28. Andujar I., Recio M.C., Giner R.M., Cienfuegos-Jovellanos E., Laghi S., Muguerza B., et al. Inhibition of ulcerative colitis in mice after oral administration of a polyphenol-enriched cocoa extract is mediated by the inhibition of STAT1 and STAT3 phosphorylation in colon cells. J Agric Food Chem 2011, 59:6474-6483.
29. Lewis K., Lutgendorff F., Phan V., Soderholm J.D., Sherman P.M., McKay D.M. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 2010, 16:1138-1148.
30. Strugala V., Dettmar P.W., Pearson J.P. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease. Int J Clin Pract 2008, 62:762-769.
31. Kim Y., Ho S. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 2010, 12:319-330.
32. Dey M., Kuhn P., Ribnicky D., Premkumar V., Reuhl K., Raskin I. Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chem Biol 2010, 10:4.
33. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
34. Nadkarni M.A., Martin F.E., Jacques N.A., Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002, 148:257-266.
35. Rinttila T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004, 97:1166-1177.
36. Fu C.J., Carter J.N., Li Y., Porter J.H., Kerley M.S. Comparison of agar plate and real-time PCR on enumeration of Lactobacillus, Clostridium perfringens and total anaerobic bacteria in dog faeces. Lett Appl Microbiol 2006, 42:490-494.
37. Wang R.-F., Cao W.-W., Cerniglia C.E. PCR detection and quantification of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol 1996, 62:1242-1247.
38. Huijsdens X.W., Linskens R.K., Mak M., Meuwissen S.G.M., Vandenbroucke-Grauls C.M.J.E., Savelkoul P.H.M. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 2002, 40:4423-4427.
39. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009, 101:541-550.